{"id":"https://openalex.org/W7147543377","doi":"https://doi.org/10.1016/j.jddst.2026.108296","title":"Mesoporous silica\u2013based tablets to improve oral delivery of carbamazepine","display_name":"Mesoporous silica\u2013based tablets to improve oral delivery of carbamazepine","publication_year":2026,"publication_date":"2026-04-02","ids":{"openalex":"https://openalex.org/W7147543377","doi":"https://doi.org/10.1016/j.jddst.2026.108296"},"language":"en","primary_location":{"id":"doi:10.1016/j.jddst.2026.108296","doi":"https://doi.org/10.1016/j.jddst.2026.108296","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jddst.2026.108296","pdf_url":null,"source":{"id":"https://openalex.org/S97205441","display_name":"Journal of Drug Delivery Science and Technology","issn_l":"1773-2247","issn":["1773-2247","2588-8943"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery Science and Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jddst.2026.108296","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108998674","display_name":"Mohamad Anas Al Tahan","orcid":"https://orcid.org/0009-0006-0956-0487","observed_orcids":["https://orcid.org/0009-0006-0956-0487"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mohamad Anas Al Tahan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-0956-0487","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023869823","display_name":"Mandeep Kaur Marwah","orcid":"https://orcid.org/0000-0003-4881-003X","observed_orcids":["https://orcid.org/0000-0003-4881-003X"]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mandeep Marwah","raw_affiliation_strings":["Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-4881-003X","affiliations":[{"raw_affiliation_string":"Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I169199633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052293605","display_name":"Mohammad Abdulraouf OTHMAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I875646752","display_name":"Damascus University","ror":"https://ror.org/03m098d13","country_code":"SY","type":"education","lineage":["https://openalex.org/I875646752"]}],"countries":["SY"],"is_corresponding":false,"raw_author_name":"Mohammad Abdulraouf Othman","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic","institution_ids":["https://openalex.org/I875646752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071529139","display_name":"Hind El-Zein","orcid":"https://orcid.org/0009-0007-1915-5706","observed_orcids":["https://orcid.org/0009-0007-1915-5706"]},"institutions":[{"id":"https://openalex.org/I875646752","display_name":"Damascus University","ror":"https://ror.org/03m098d13","country_code":"SY","type":"education","lineage":["https://openalex.org/I875646752"]}],"countries":["SY"],"is_corresponding":false,"raw_author_name":"Hind El-Zein","raw_affiliation_strings":["Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic","institution_ids":["https://openalex.org/I875646752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128935937","display_name":"Craig Russell","orcid":"https://orcid.org/0000-0003-3791-2161","observed_orcids":["https://orcid.org/0000-0003-3791-2161"]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Craig Russell","raw_affiliation_strings":["School of Pharmacy, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-3791-2161","affiliations":[{"raw_affiliation_string":"School of Pharmacy, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I169199633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132640269","display_name":"Courtney Harris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Courtney Harris","raw_affiliation_strings":["Aston Advanced Materials, College of Engineering and Physical Sciences, Aston University, Birmingham, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aston Advanced Materials, College of Engineering and Physical Sciences, Aston University, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I169199633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035932719","display_name":"Stephen D. Worrall","orcid":"https://orcid.org/0000-0003-1969-3671","observed_orcids":["https://orcid.org/0000-0003-1969-3671"]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Worrall","raw_affiliation_strings":["Aston Advanced Materials, College of Engineering and Physical Sciences, Aston University, Birmingham, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-1969-3671","affiliations":[{"raw_affiliation_string":"Aston Advanced Materials, College of Engineering and Physical Sciences, Aston University, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I169199633"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132636893","display_name":"Anna Peat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anna Peat","raw_affiliation_strings":["Faculty of Biochemistry, Department of Life Sciences, University of Bath, Bath, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Biochemistry, Department of Life Sciences, University of Bath, Bath, United Kingdom","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126047893","display_name":"Kacper Kruszyna","orcid":"https://orcid.org/0009-0001-2097-1088","observed_orcids":["https://orcid.org/0009-0001-2097-1088"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kacper Kruszyna","raw_affiliation_strings":["Faculty of Pharmacy and Pharmacology, Department of Life Sciences, University of Bath, Bath, United Kingdom"],"raw_orcid":"https://orcid.org/0009-0001-2097-1088","affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy and Pharmacology, Department of Life Sciences, University of Bath, Bath, United Kingdom","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126043603","display_name":"Jacob Baxandall","orcid":"https://orcid.org/0009-0008-0396-7328","observed_orcids":["https://orcid.org/0009-0008-0396-7328"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jacob Baxandall","raw_affiliation_strings":["Faculty of Natural Sciences, Department of Life Sciences, University of Bath, Bath, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Natural Sciences, Department of Life Sciences, University of Bath, Bath, United Kingdom","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044912554","display_name":"Lissette Carolina Sanchez-Aranguren","orcid":"https://orcid.org/0000-0002-4663-5752","observed_orcids":["https://orcid.org/0000-0002-4663-5752"]},"institutions":[{"id":"https://openalex.org/I169199633","display_name":"Aston University","ror":"https://ror.org/05j0ve876","country_code":"GB","type":"education","lineage":["https://openalex.org/I169199633"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Lissette Sanchez-Aranguren","raw_affiliation_strings":["Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-4663-5752","affiliations":[{"raw_affiliation_string":"Aston Medical School, College of Health and Life Sciences, Aston University, Birmingham, United Kingdom","institution_ids":["https://openalex.org/I169199633"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5044912554","https://openalex.org/A5108998674"],"corresponding_institution_ids":["https://openalex.org/I169199633"],"apc_list":{"value":3810,"currency":"USD","value_usd":3810},"apc_paid":{"value":3810,"currency":"USD","value_usd":3810},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"121","issue":null,"first_page":"108296","last_page":"108296"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9394999742507935,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10735","display_name":"Mesoporous Materials and Catalysis","score":0.042899999767541885,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.996999979019165},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.9100000262260437},{"id":"https://openalex.org/keywords/solubility-enhancement","display_name":"solubility enhancement","score":0.9079999923706055},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.8399999737739563},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8999999761581421},{"id":"https://openalex.org/keywords/drug-encapsulation","display_name":"drug encapsulation","score":0.765999972820282},{"id":"https://openalex.org/keywords/amorphous-drug-dispersion","display_name":"amorphous drug dispersion","score":0.8399999737739563},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.5370000004768372},{"id":"https://openalex.org/keywords/recrystallization","display_name":"recrystallization","score":0.6570000052452087},{"id":"https://openalex.org/keywords/drug-loading-efficiency","display_name":"drug loading efficiency","score":0.3610000014305115},{"id":"https://openalex.org/keywords/silanol-groups","display_name":"silanol groups","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.7559999823570251},{"id":"https://openalex.org/C82776694","wikidata":"https://www.wikidata.org/wiki/Q380049","display_name":"Mesoporous material","level":3,"score":0.5918999910354614},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4918000102043152},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44929999113082886},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.3765000104904175},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.37540000677108765},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.32589998841285706},{"id":"https://openalex.org/C2777496208","wikidata":"https://www.wikidata.org/wiki/Q17156473","display_name":"Mesoporous silica","level":4,"score":0.3149999976158142},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.3066999912261963},{"id":"https://openalex.org/C2983812674","wikidata":"https://www.wikidata.org/wiki/Q134808","display_name":"Delivery system","level":2,"score":0.29670000076293945},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.287200003862381},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.27489998936653137},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.2612000107765198},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.25380000472068787},{"id":"https://openalex.org/C2777239854","wikidata":"https://www.wikidata.org/wiki/Q902638","display_name":"Excipient","level":2,"score":0.2526000142097473},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.2515999972820282}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.jddst.2026.108296","doi":"https://doi.org/10.1016/j.jddst.2026.108296","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jddst.2026.108296","pdf_url":null,"source":{"id":"https://openalex.org/S97205441","display_name":"Journal of Drug Delivery Science and Technology","issn_l":"1773-2247","issn":["1773-2247","2588-8943"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery Science and Technology","raw_type":"journal-article"},{"id":"pmh:oai:publications.aston.ac.uk:48979","doi":null,"is_oa":true,"landing_page_url":"https://publications.aston.ac.uk/id/eprint/48979/","pdf_url":"https://publications.aston.ac.uk/id/eprint/48979/1/MA_Al_Tahan_et_al_Mesoporous_silica_based_tablets_to_improve_oral_delivery_of_carbamazepine.pdf","source":{"id":"https://openalex.org/S4306400483","display_name":"Aston Publications Explorer (Aston University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169199633","host_organization_name":"Aston University","host_organization_lineage":["https://openalex.org/I169199633"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.jddst.2026.108296","doi":"https://doi.org/10.1016/j.jddst.2026.108296","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jddst.2026.108296","pdf_url":null,"source":{"id":"https://openalex.org/S97205441","display_name":"Journal of Drug Delivery Science and Technology","issn_l":"1773-2247","issn":["1773-2247","2588-8943"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Drug Delivery Science and Technology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323026","display_name":"Aston University","ror":"https://ror.org/05j0ve876"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7147543377.pdf","grobid_xml":"https://content.openalex.org/works/W7147543377.grobid-xml"},"referenced_works_count":71,"referenced_works":["https://openalex.org/W350348219","https://openalex.org/W1965970894","https://openalex.org/W1966899164","https://openalex.org/W1967060892","https://openalex.org/W1971181330","https://openalex.org/W1998604003","https://openalex.org/W1999026740","https://openalex.org/W2006369950","https://openalex.org/W2009242118","https://openalex.org/W2014905154","https://openalex.org/W2020559862","https://openalex.org/W2033297292","https://openalex.org/W2034427370","https://openalex.org/W2034515226","https://openalex.org/W2034791599","https://openalex.org/W2039241045","https://openalex.org/W2048462713","https://openalex.org/W2067596892","https://openalex.org/W2086705246","https://openalex.org/W2094133489","https://openalex.org/W2102618395","https://openalex.org/W2154404145","https://openalex.org/W2167279371","https://openalex.org/W2585439647","https://openalex.org/W2604404809","https://openalex.org/W2607416740","https://openalex.org/W2618800110","https://openalex.org/W2739931821","https://openalex.org/W2788014396","https://openalex.org/W2790457655","https://openalex.org/W2868336129","https://openalex.org/W2905300541","https://openalex.org/W2922847814","https://openalex.org/W2947171171","https://openalex.org/W2949454978","https://openalex.org/W2964305381","https://openalex.org/W3034288346","https://openalex.org/W3095709087","https://openalex.org/W3119323056","https://openalex.org/W3136677713","https://openalex.org/W3159041338","https://openalex.org/W3165009558","https://openalex.org/W3174027932","https://openalex.org/W3214089475","https://openalex.org/W4200513381","https://openalex.org/W4205168864","https://openalex.org/W4205946444","https://openalex.org/W4290791008","https://openalex.org/W4297988191","https://openalex.org/W4309683850","https://openalex.org/W4328102486","https://openalex.org/W4367299921","https://openalex.org/W4380882593","https://openalex.org/W4389100985","https://openalex.org/W4394992636","https://openalex.org/W4396634142","https://openalex.org/W4399771851","https://openalex.org/W4400280761","https://openalex.org/W4401275096","https://openalex.org/W4401828037","https://openalex.org/W4402327450","https://openalex.org/W4402897733","https://openalex.org/W4403274547","https://openalex.org/W4403380622","https://openalex.org/W4404493263","https://openalex.org/W4405664032","https://openalex.org/W4408543458","https://openalex.org/W4410023144","https://openalex.org/W4411666020","https://openalex.org/W4416269525","https://openalex.org/W7128799893"],"related_works":["https://openalex.org/W2048462713","https://openalex.org/W2086705246","https://openalex.org/W2067682657","https://openalex.org/W2618800110","https://openalex.org/W3003767427","https://openalex.org/W3148199792","https://openalex.org/W4399617345","https://openalex.org/W3095709087","https://openalex.org/W4327968175","https://openalex.org/W1993419053"],"abstract_inverted_index":{"Epilepsy":[0],"affects":[1],"around":[2],"50":[3],"million":[4],"people":[5],"worldwide,":[6],"requiring":[7],"long-term":[8],"antiepileptic":[9],"drug":[10,55,69,79,104],"(AED)":[11],"therapy.":[12],"Carbamazepine,":[13],"a":[14,139,149,190],"widely":[15],"used":[16],"AED,":[17],"effectively":[18],"manages":[19],"seizures":[20],"and":[21,54,87,95,102,109,128,167,176,197,203],"neuropathic":[22],"pain.":[23],"However,":[24],"its":[25],"poor":[26],"water":[27],"solubility":[28,53,143,196],"limits":[29],"bioavailability,":[30,198],"necessitating":[31],"higher":[32],"doses":[33],"that":[34],"increase":[35],"the":[36,118,133,137],"risk":[37],"of":[38,72,136,154],"side":[39,201],"effects.":[40],"To":[41],"address":[42],"this,":[43],"we":[44],"developed":[45],"carbamazepine-loaded":[46],"mesoporous":[47,186],"silica":[48,119,187],"microparticles":[49,188],"(SYLOID\u00ae)":[50],"to":[51,84,193],"enhance":[52,194],"release.":[56],"Carbamazepine":[57,179],"was":[58,82],"incorporated":[59],"at":[60],"20\u2013100%":[61],"w/w":[62],"(drug-to-carrier)":[63],"theoretical":[64],"loading":[65,90],"ratio,":[66],"achieving":[67],"actual":[68],"load":[70],"values":[71],"84\u201397%.":[73],"Fourier-transform":[74],"infrared":[75],"spectroscopy":[76],"(FTIR)":[77],"confirmed":[78,132],"incorporation,":[80],"which":[81],"attributed":[83],"solvent":[85],"viscosity":[86],"polarity,":[88],"improving":[89,204],"efficiency.":[91],"Interactions":[92],"between":[93],"carbamazepine":[94,163,195],"SYLOID\u00ae":[96],"silanol":[97],"groups":[98],"weakened":[99],"molecular":[100],"bonds":[101],"enhanced":[103],"entrapment.":[105],"Fluorescence-based":[106],"3D":[107],"imaging":[108],"scanning":[110,125],"electron":[111],"microscopy":[112],"(SEM)":[113],"revealed":[114],"crystalline":[115],"formations":[116],"on":[117],"surface,":[120],"suggesting":[121],"partial":[122],"recrystallisation.":[123],"Differential":[124],"calorimetry":[126],"(DSC)":[127],"X-ray":[129],"diffraction":[130],"(XRD)":[131],"amorphous":[134],"dispersion":[135],"drug,":[138],"key":[140],"factor":[141],"in":[142,151],"enhancement.":[144],"Mesoporous":[145],"silica-based":[146],"tablets":[147],"achieved":[148],"cumulative":[150],"vitro":[152],"release":[153],"98.25":[155],"\u00b1":[156,165,174,181],"3.28%":[157],"after":[158],"6":[159],"h,":[160],"outperforming":[161],"unformulated":[162],"(67.12":[164],"4.11%)":[166],"commercial":[168],"formulations":[169],"such":[170],"as":[171,189],"Tegretol\u00ae":[172],"(81.87":[173],"6.49%)":[175],"Crescent":[177],"Pharma's":[178],"(83.12":[180],"0.68%).":[182],"These":[183],"findings":[184],"highlight":[185],"promising":[191],"approach":[192],"potentially":[199],"reducing":[200],"effects":[202],"therapeutic":[205],"outcomes.":[206]},"counts_by_year":[],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2026-04-02T00:00:00"}